Prognostic Factor Analysis of Intraocular Pressure with Neovascular Glaucoma

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static-preview.hindawi.com/articles/joph/volume-2016/1205895/figures/1205895.fig.007a.svgz" name="1205895.fig.007a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Additional PRP</td></tr><tr class="fig-image" id="b"><td><object data="https://static-preview.hindawi.com/articles/joph/volume-2016/1205895/figures/1205895.fig.007b.svgz" name="1205895.fig.007b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>PPV</td></tr><tr class="fig-image" id="c"><td><object data="https://static-preview.hindawi.com/articles/joph/volume-2016/1205895/figures/1205895.fig.007c.svgz" name="1205895.fig.007c" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(c) </b>LEC</td></tr></table>

<div>Long-term prognosis of each treatment with or without anti-VEGF combination therapy (univariate analysis). Anti-VEGF combination therapy had no positive impact on long-term prognosis.</div>

Journal of Ophthalmology

fig7

Figure 7

Figure 7: Prognostic Factor Analysis of Intraocular Pressure with Neovascular Glaucoma 